Equitable Trust Co. Sells 205 Shares of Intuitive Surgical, Inc. $ISRG

Equitable Trust Co. reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.5% in the 2nd quarter, Holdings Channel reports. The firm owned 2,949 shares of the medical equipment provider’s stock after selling 205 shares during the quarter. Equitable Trust Co.’s holdings in Intuitive Surgical were worth $1,603,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the stock. IFC Advisors LLC raised its position in Intuitive Surgical by 3.3% during the 2nd quarter. IFC Advisors LLC now owns 722 shares of the medical equipment provider’s stock worth $392,000 after purchasing an additional 23 shares during the last quarter. RFG Advisory LLC raised its position in Intuitive Surgical by 4.2% during the 2nd quarter. RFG Advisory LLC now owns 3,374 shares of the medical equipment provider’s stock worth $1,833,000 after purchasing an additional 136 shares during the last quarter. Axxcess Wealth Management LLC raised its position in Intuitive Surgical by 24.0% during the 2nd quarter. Axxcess Wealth Management LLC now owns 11,017 shares of the medical equipment provider’s stock worth $5,987,000 after purchasing an additional 2,129 shares during the last quarter. Moran Wealth Management LLC raised its position in Intuitive Surgical by 44.0% during the 2nd quarter. Moran Wealth Management LLC now owns 2,476 shares of the medical equipment provider’s stock worth $1,345,000 after purchasing an additional 757 shares during the last quarter. Finally, Cornerstone Wealth Group LLC raised its position in Intuitive Surgical by 20.1% during the 2nd quarter. Cornerstone Wealth Group LLC now owns 764 shares of the medical equipment provider’s stock worth $415,000 after purchasing an additional 128 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the company. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, October 4th. UBS Group set a $529.00 price objective on Intuitive Surgical in a research report on Monday. Zacks Research lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. Evercore ISI lowered their price objective on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating for the company in a research report on Tuesday, October 7th. Finally, BTIG Research lowered their price objective on Intuitive Surgical from $571.00 to $529.00 and set a “buy” rating for the company in a research report on Monday. Fourteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $585.71.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $436.39 on Wednesday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The firm has a market capitalization of $156.44 billion, a price-to-earnings ratio of 60.86, a PEG ratio of 4.58 and a beta of 1.61. The business has a 50-day simple moving average of $456.92 and a 200 day simple moving average of $497.02.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. During the same period in the previous year, the company posted $1.78 EPS. The firm’s revenue was up 21.4% compared to the same quarter last year. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Activity at Intuitive Surgical

In related news, Director Amy L. Ladd sold 335 shares of the business’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director directly owned 739 shares of the company’s stock, valued at $325,669.91. The trade was a 31.19% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president owned 353 shares of the company’s stock, valued at $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock valued at $21,716,492 in the last three months. Corporate insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.